Nucleoside Phosphoramidates
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/179,923, filed May 20, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,629,263 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 8,633,309 | Nucleoside Phosphoramidates In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | ||
| US 8,642,756 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 8,735,569 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 9,206,217 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 9,284,342 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 8,618,076 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 9,637,512 | Nucleoside Phosphoramidates In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| Application 18/054,489 | Nucleoside Phosphoramidates Abandoned Abandoned Aug 2, 2023 | Gilead Sciences, Inc. | Abandoned | Abandoned Aug 2, 2023 | ||
| Application 18/343,311 | Nucleoside Phosphoramidates Abandoned Abandoned Feb 29, 2024 | Gilead Sciences, Inc. | Abandoned | Abandoned Feb 29, 2024 | ||
| 1 more patent in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
8 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.